Methallylescaline

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Edgar181 (talk | contribs) at 15:44, 28 March 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Methallylescaline
Names
IUPAC name
2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C14H21NO3/c1-10(2)9-18-14-12(16-3)7-11(5-6-15)8-13(14)17-4/h7-8H,1,5-6,9,15H2,2-4H3 checkY
    Key: FOXJFBFFGULACD-UHFFFAOYSA-N checkY
  • InChI=1/C14H21NO3/c1-10(2)9-18-14-12(16-3)7-11(5-6-15)8-13(14)17-4/h7-8H,1,5-6,9,15H2,2-4H3
    Key: FOXJFBFFGULACD-UHFFFAOYAG
  • CC(=C)COc1c(cc(cc1OC)CCN)OC
Properties
C14H21NO3
Molar mass 251.326 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Methallylescaline (4-methylallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is also the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 40–65 mg and the duration is listed as 12–16 hours.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline.

Legal status

Allylescaline is illegal in Sweden as of 26 January 2016.[2]

See also

References

  1. ^ Methallylescaline entry in PiHKAL
  2. ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.

Template:PiHKAL